Ultragenyx Pharmaceutical | Brutto Fortjeneste På Salg

Gross Profit On Sales Endring Dato
Acadia Pharmaceuticals USD 182.88M 30.27M 2024-03
Agios Pharmaceuticals USD 7.56M 1.04M 2024-03
Alnylam Pharmaceuticals USD 428.36M 74.5M 2024-03
BioMarin Pharmaceutical USD 523.65M 12.92M 2024-03
Insmed USD 58.04M 7.21M 2024-03
Ionis Pharmaceuticals USD 117.35M 204.1M 2024-03
Kyowa Hakko Kirin JPY 79.98B 21.96B 2024-03
MacroGenics USD 6.99M 3.57M 2024-03
Moderna USD 71M 1.81B 2024-03
Neurocrine Biosciences USD 507.8M 20.2M 2024-03
PTC Therapeutics USD 195.38M 82.56M 2024-03
Regeneron Pharmaceuticals USD 2.71B 206.1M 2024-03
Sarepta Therapeutics USD 362.9M 68.11M 2024-03
Ultragenyx Pharmaceutical USD 91.3M 24.04M 2024-03
Vertex Pharmaceuticals USD 2.35B 183.2M 2024-03



Ultragenyx Pharmaceutical Brutto Fortjeneste På Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.